Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1733-1744

  Hsu, Ya Ling ^a   Huang, Ming Shyan ^b   Cheng, Da En ^a   Hung, Jen Yu ^a,b   Yang, Chih Jen ^a,b   Chou, Shah Hwa ^b   Kuo, Po Lin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; AMPHIREGULIN ANTIBODY; CYCLIN D; GLYCOPROTEIN P 15095; PROTEIN ANTIBODY; PROTEIN KINASE B; STAT3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR ASSOCIATED DENDRITIC CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD11C; BONE NEOPLASMS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TWIST TRANSCRIPTION FACTOR;

EID: 80051916135     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100996     Document Type: Article

References (33)

1. Jemal, A., R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun. 2009. Cancer statistics, 2009. CA Cancer J. Clin. 59: 225-249.
2. Doedens, A. L., C. Stockmann, M. P. Rubinstein, D. Liao, N. Zhang, D. G. DeNardo, L. M. Coussens, M. Karin, A. W. Goldrath, and R. S. Johnson. 2010. Macrophage expression of hypoxia-inducible factor-1α suppresses T-cell function and promotes tumor progression. Cancer Res. 70: 7465-7475.
3. Barnas, J. L., M. R. Simpson-Abelson, S. P. Brooks, R. J. Kelleher, Jr., and R. B. Bankert. 2010. Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors. J. Immunol. 185: 2681-2692.
4. Plantinga, M., H. Hammad, and B. N. Lambrecht. 2010. Origin and functional specializations of DC subsets in the lung. Eur. J. Immunol. 40: 2112-2118.
5. Kuo, P. L., J. Y. Hung, S. K. Huang, S. H. Chou, D. E. Cheng, Y. J. Jong, C. H. Hung, C. J. Yang, Y. M. Tsai, Y. L. Hsu, and M. S. Huang. 2011. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway. J. Immunol. 186: 1521-1530.
6. Perrot, I., D. Blanchard, N. Freymond, S. Isaac, B. Guibert, Y. Pachéco, and S. Lebecque. 2007. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J. Immunol. 178: 2763-2769. (Pubitemid 46333153)
7. Robinson-Smith, T. M., I. Isaacsohn, C. A. Mercer, M. Zhou, N. Van Rooijen, N. Husseinzadeh, M. M. McFarland-Mancini, and A. F. Drew. 2007. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res. 67: 5708-5716. (Pubitemid 46985003)
8. Lu, X., Q. Wang, G. Hu, C. Van Poznak, M. Fleisher, M. Reiss, J. Massagué, and Y. Kang. 2009. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 23: 1882-1894.
9. Yamada, M., Y. Ichikawa, S. Yamagishi, N. Momiyama, M. Ota, S. Fujii, K. Tanaka, S. Togo, S. Ohki, and H. Shimada. 2008. Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer. Clin. Cancer Res. 14: 2351-2356. (Pubitemid 351551067)
10. Gilmore, J. L., R. M. Gonterman, K. Menon, G. Lorch, D. J. Riese, II, A. Robling, and J. Foley. 2009. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. Mol. Cancer Res. 7: 1714-1728.
11. Li, X. D., S. Y. Miao, G. L. Wang, L. Yang, Y. Q. Shu, and Y. M. Yin. 2010. Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics. Onkologie 33: 353-358.
12. Yotsumoto, F., T. Fukami, H. Yagi, A. Funakoshi, T. Yoshizato, M. Kuroki, and S. Miyamoto. 2010. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. Cancer Sci. 101: 2351-2360.
13. Bles, N., L. Di Pietrantonio, J. M. Boeynaems, and D. Communi. 2010. ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion. Blood 116: 3219-3226.
14. Addison, C. L., K. Ding, H. Zhao, A. Le Maître, G. D. Goss, L. Seymour, M. S. Tsao, F. A. Shepherd, and P. A. Bradbury. 2010. Plasma transforming growth factor a and amphiregulin protein levels in NCIC Clinical Trials Group BR.21. J. Clin. Oncol. 28: 5247-5256.
15. Berasain, C., E. R. García-Trevijano, J. Castillo, E. Erroba, M. Santamaría, D. C. Lee, J. Prieto, and M. A. Avila. 2005. Novel role for amphiregulin in protection from liver injury. J. Biol. Chem. 280: 19012-19020. (Pubitemid 41379606)
16. Lo, H. W., S. C. Hsu, W. Xia, X. Cao, J. Y. Shih, Y. Wei, J. L. Abbruzzese, G. N. Hortobagyi, and M. C. Hung. 2007. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67: 9066-9076. (Pubitemid 47535891)
17. Kuo, P. L., Y. H. Chen, T. C. Chen, K. H. Shen, and Y. L. Hsu. 2011. CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway. J. Cell. Physiol. 226: 1224-1231.
18. Vicent, S., D. Luis-Ravelo, I. Antón, I. García- Tunón, F. Borrás-Cuesta, J. Dotor, J. De Las Rivas, and F. Lecanda. 2008. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res. 68: 2275-2285.
19. Hsu, Y. L., J. Y. Hung, Y. C. Ko, C. H. Hung, M. S. Huang, and P. L. Kuo. 2010. Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis. Carcinogenesis 31: 587-596.
20. Kim, M. Y., T. Oskarsson, S. Acharyya, D. X. Nguyen, X. H. Zhang, L. Norton, and J. Massagué. 2009. Tumor self-seeding by circulating cancer cells. Cell 139: 1315-1326.
21. McAllister, S. S., and R. A. Weinberg. 2010. Tumor-host interactions: A far-reaching relationship. J. Clin. Oncol. 28: 4022-4028.
22. Xian, C. J. 2007. Roles of epidermal growth factor family in the regulation of postnatal somatic growth. Endocr. Rev. 28: 284-296. (Pubitemid 46991959)
23. Schuger, L., G. R. Johnson, K. Gilbride, G. D. Plowman, and R. Mandel. 1996. Amphiregulin in lung branching morphogenesis: Interaction with heparan sulfate proteoglycan modulates cell proliferation. Development 122: 1759-1767. (Pubitemid 26192741)
24. Berasain, C., J. Castillo, M. J. Perugorría, J. Prieto, and M. A. Avila. 2007. Amphiregulin: A new growth factor in hepatocarcinogenesis. Cancer Lett. 254: 30-41. (Pubitemid 47058802)
25. Willmarth, N. E., and S. P. Ethier. 2008. Amphiregulin as a novel target for breast cancer therapy. J. Mammary Gland Biol. Neoplasia 13: 171-179.
26. Hurbin, A., J. L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, and M. C. Favrot. 2005. Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J. Biol. Chem. 280: 19757-19767. (Pubitemid 41379501)
27. Eckstein, N., K. Servan, L. Girard, D. Cai, G. Von Jonquieres, U. Jaehde, M. U. Kassack, A. F. Gazdar, J. D. Minna, and H. D. Royer. 2008. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283: 739-750.
28. Behera, R., V. Kumar, K. Lohite, S. Karnik, and G. C. Kundu. 2010. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31: 192-200.
29. Barbieri, I., S. Pensa, T. Pannellini, E. Quaglino, D. Maritano, M. Demaria, A. Voster, J. Turkson, F. Cavallo, C. J. Watson, et al. 2010. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Cancer Res. 70: 2558-2567.
30. Catalano, S., C. Giordano, P. Rizza, G. Gu, I. Barone, D. Bonofiglio, F. Giordano, R. Malivindi, D. Gaccione, M. Lanzino, et al. 2009. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. J. Cell. Physiol. 218: 490-500.
31. Hung, J. J., M. H. Yang, H. S. Hsu, W. H. Hsu, J. S. Liu, and K. J. Wu. 2009. Prognostic significance of hypoxia-inducible factor-1α, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 64: 1082-1089.
32. Fukumoto, J., C. Harada, T. Kawaguchi, S. Suetsugu, T. Maeyama, I. Inoshima, N. Hamada, K. Kuwano, and Y. Nakanishi. 2010. Amphiregulin attenuates bleomycin-induced pneumopathy in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L131-L138.
33. Qian, J., Y. Zou, J. S. Rahman, B. Lu, and P. P. Massion. 2009. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol. Cancer Ther. 8: 101-109.